Ruben Sanchez

Ruben Sanchez has over 20 years of experience in regulatory affairs. Ruben currently holds the role of Vice President of Regulatory Affairs at CG Oncology since August 2020. Prior to this, they served as the Senior Director of Regulatory Affairs at Revance Therapeutics, Inc. from October 2019 to August 2020. From April 2017 to September 2019, they held the position of Senior Director of Regulatory Affairs at SillaJen Inc. Ruben has also held various regulatory affairs positions at other pharmaceutical companies such as Adamas Pharmaceuticals, Inc., Onyx Pharmaceuticals, Maxygen, Genitope Corporation, PDL BioPharma, Elan Pharmaceuticals, and PAREXEL.

Ruben Sanchez attended Sonoma State University from 1990 to 1995, earning a Bachelor of Science degree in Chemistry.